How rare is a paraneoplastic syndrome that is anti‑Yo (anti‑PCA‑1) positive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Rare is Anti-Yo Positive Paraneoplastic Syndrome?

Anti-Yo positive paraneoplastic cerebellar degeneration is the most common variant of paraneoplastic cerebellar degeneration, but paraneoplastic neurological syndromes themselves are rare conditions 1.

Epidemiological Context

Anti-Yo antibody (also called Purkinje cell cytoplasmic antibody type 1 or PCA-1) represents the most frequently detected autoantibody in paraneoplastic cerebellar degeneration 2, 1. However, this "most common" designation must be understood within the context that all classical paraneoplastic CNS syndromes are rare disorders 3.

Key Demographic Patterns

The vast majority of anti-Yo PCD cases occur in:

  • Women over 60 years old 2
  • Associated with gynecologic tumors (ovarian or breast cancer) 4, 1
  • Only 10 cases have been reported in males as of 2013 2
  • Only 2 male cases were associated with lung cancer 2

Clinical Rarity Indicators

Several factors underscore the rarity of this condition:

  • The low prevalence has not allowed for large-scale randomized controlled trials 1, which is a hallmark of extremely rare conditions
  • Case reports of anti-Yo PCD in atypical presentations (males, lung cancer, benign tumors) are published as novel findings 4, 2, 5
  • The 2013 case report described "the youngest known case of PCA-1 positive PCD in a male" 2, indicating that individual cases warrant publication

Practical Implications

Despite being rare, cancer screening should be considered in most adult autoimmune encephalitis patients at presentation 6 because:

  • Neurological symptoms typically precede cancer diagnosis 7, 8
  • The antibody presence indicates need for thorough tumor search
  • Early tumor detection and treatment is essential for both neurological prognosis and overall survival 7

Common Associated Malignancies

When anti-Yo PCD does occur, expect:

  • Ovarian cancer (most common)
  • Breast cancer (second most common) 1, 8
  • Rarely: lung cancer 4, 2, or even benign tumors 5

The prognosis for anti-Yo PCD is almost uniformly poor, with most patients left bedridden 1, making early recognition critical despite its rarity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.